Bing Zhou

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 33

Top Topics

Acute Myeloid Leukemia

Anti Inflammatory

Top Venues

Journal of medicinal chemistry

Organic letters

Chemical science

This page only lists publications with an associated author ORCID identifier.

Publications

Chao Chen, Yanni Chen, Zijian Han, Yujie Huang, Yujiao Wang, Xiuyu Tao, Lan Wang, Xiangli Chen, Ruikai Long, Yaxi Yang, Weiliang Zhu, Bing Zhou
Switchable Regioselective C-H Activation/Annulation of Acrylamides with Alkynes for the Synthesis of 2-Pyridones. ChemSusChem (2024)
Miaomiao Xu, Jingfeng Fu, Yuan Pei, Mengna Li, Weijuan Kan, Ruyu Yan, Chaoyue Xia, Jingkun Ma, Peipei Wang, Yan Zhang, Yue Gao, Yaxi Yang, Yubo Zhou, Jia Li, Bing Zhou
Discovery of a Highly Potent, Selective and Efficacious USP7 Degrader for the Treatment of Acute Lymphoblastic Leukemia. Journal of medicinal chemistry (2024)
Yunkai Shi, Minmin Liu, Mengna Li, Yiwen Mao, Jingkun Ma, Ruikai Long, Miaomiao Xu, Yaxi Yang, Wenlong Wang, Yubo Zhou, Jia Li, Bing Zhou
Discovery of potent PROTAC degraders of Pin1 for the treatment of acute myeloid leukemia. Chemical science 15 (13) (2024)
Yuying Suo, Daohai Du, Chao Chen, Hongwen Zhu, Xiongjun Wang, Nixue Song, Dayun Lu, Yaxi Yang, Jiacheng Li, Jun Wang, Zhongyuan Luo, Bing Zhou, Cheng Luo, Hu Zhou
Uncovering PROTAC Sensitivity and Efficacy by Multidimensional Proteome Profiling: A Case for STAT3. Journal of medicinal chemistry (2024)
Yunkai Shi, Qianqian Shen, Ruikai Long, Yiwen Mao, Shuaihang Tong, Yaxi Yang, Jing Gao, Hu Zhou, Yi Chen, Bing Zhou
Discovery of Potent and Selective G9a Degraders for the Treatment of Pancreatic Cancer. Journal of medicinal chemistry 67 (15) (2024)
Wanyi Zou, Mengna Li, Shili Wan, Jingkun Ma, Linan Lian, Guanghao Luo, Yubo Zhou, Jia Li, Bing Zhou
Discovery of PRMT3 Degrader for the Treatment of Acute Leukemia. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)
Yunkai Shi, Minmin Liu, Mengna Li, Yiwen Mao, Jingkun Ma, Ruikai Long, Miaomiao Xu, Yaxi Yang, Wenlong Wang, Yubo Zhou, Jia Li, Bing Zhou
Discovery of potent PROTAC degraders of Pin1 for the treatment of acute myeloid leukemia. Chemical science 15 (13) (2024)
Yuying Suo, Daohai Du, Chao Chen, Hongwen Zhu, Xiongjun Wang, Nixue Song, Dayun Lu, Yaxi Yang, Jiacheng Li, Jun Wang, Zhongyuan Luo, Bing Zhou, Cheng Luo, Hu Zhou
Uncovering PROTAC Sensitivity and Efficacy by Multidimensional Proteome Profiling: A Case for STAT3. Journal of medicinal chemistry 67 (6) (2024)
Yuying Suo, Daohai Du, Chao Chen, Hongwen Zhu, Xiongjun Wang, Nixue Song, Dayun Lu, Yaxi Yang, Jiacheng Li, Jun Wang, Zhongyuan Luo, Bing Zhou, Cheng Luo, Hu Zhou
Uncovering PROTAC Sensitivity and Efficacy by Multidimensional Proteome Profiling: A Case for STAT3. Journal of medicinal chemistry 67 (6) (2024)
Yunkai Shi, Qianqian Shen, Ruikai Long, Yiwen Mao, Shuaihang Tong, Yaxi Yang, Jing Gao, Hu Zhou, Yi Chen, Bing Zhou
Discovery of Potent and Selective G9a Degraders for the Treatment of Pancreatic Cancer. Journal of medicinal chemistry (2024)
Miaomiao Xu, Jingfeng Fu, Yuan Pei, Mengna Li, Weijuan Kan, Ruyu Yan, Chaoyue Xia, Jingkun Ma, Peipei Wang, Yan Zhang, Yue Gao, Yaxi Yang, Yubo Zhou, Jia Li, Bing Zhou
Discovery of a Highly Potent, Selective and Efficacious USP7 Degrader for the Treatment of Acute Lymphoblastic Leukemia. Journal of medicinal chemistry 67 (15) (2024)
Yunkai Shi, Qianqian Shen, Ruikai Long, Yiwen Mao, Shuaihang Tong, Yaxi Yang, Jing Gao, Hu Zhou, Yi Chen, Bing Zhou
Discovery of Potent and Selective G9a Degraders for the Treatment of Pancreatic Cancer. Journal of medicinal chemistry 67 (15) (2024)
Liuyu Hu, Yipei Gu, Ju Liang, Mengmeng Ning, Junli Yang, Yi Zhang, Hui Qu, Yaxi Yang, Ying Leng, Bing Zhou
Discovery of Highly Potent and Selective Thyroid Hormone Receptor β Agonists for the Treatment of Nonalcoholic Steatohepatitis. Journal of medicinal chemistry (2023)
Liuyu Hu, Yipei Gu, Ju Liang, Mengmeng Ning, Junli Yang, Yi Zhang, Hui Qu, Yaxi Yang, Ying Leng, Bing Zhou
Discovery of Highly Potent and Selective Thyroid Hormone Receptor β Agonists for the Treatment of Nonalcoholic Steatohepatitis. Journal of medicinal chemistry 66 (5) (2023)
Liuyu Hu, Yipei Gu, Ju Liang, Mengmeng Ning, Junli Yang, Yi Zhang, Hui Qu, Yaxi Yang, Ying Leng, Bing Zhou
Discovery of Highly Potent and Selective Thyroid Hormone Receptor β Agonists for the Treatment of Nonalcoholic Steatohepatitis. Journal of medicinal chemistry 66 (5) (2023)
Liuyu Hu, Yipei Gu, Ju Liang, Mengmeng Ning, Junli Yang, Yi Zhang, Hui Qu, Yaxi Yang, Ying Leng, Bing Zhou
Discovery of Highly Potent and Selective Thyroid Hormone Receptor β Agonists for the Treatment of Nonalcoholic Steatohepatitis. Journal of medicinal chemistry 66 (5) (2023)
Liping Liu, Rui Zhu, Jiacheng Li, Yuan Pei, Shuangshuang Wang, Pan Xu, Mingyu Wang, Yu Wen, Hao Zhang, Daohai Du, Hong Ding, Hualiang Jiang, Kaixian Chen, Bing Zhou, Li-Fang Yu, Cheng Luo
Computational and Structure-Based Development of High Potent Cell-Active Covalent Inhibitor Targeting the Peptidyl-Prolyl Isomerase NIMA-Interacting-1 (Pin1). Journal of medicinal chemistry 65 (3) (2022)
Qilong Tan, Ziqun Liu, Xiaobo Gao, Yibo Wang, Xuefeng Qiu, Jiahui Chen, Liuchun Liang, Hongqian Guo, Shengsong Huang, Denglong Wu, Bing Zhou, Huiying Zhao, Zhenfei Li
Celastrol recruits UBE3A to recognize and degrade the DNA binding domain of steroid receptors. Oncogene 41 (42) (2022)
Yuan Pei, Jingfeng Fu, Yunkai Shi, Mengmeng Zhang, Guanghao Luo, Xiaomin Luo, Ning Song, Tian Mi, Yaxi Yang, Jia Li, Yubo Zhou, Bing Zhou
Discovery of a Potent and Selective Degrader for USP7. Angewandte Chemie (International ed. in English) 61 (33) (2022)
Wenwen Yu, Chao Chen, Lei Feng, Tianqi Xia, Chen Shi, Yaxi Yang, Bing Zhou
Rhodium(III)-Catalyzed Asymmetric 1,2-Carboamidation of Alkenes Enables Access to Chiral 2,3-Dihydro-3-benzofuranmethanamides. Organic letters 24 (9) (2022)
Chenxing Ji, Wen Xu, Hong Ding, Zhengyuan Chen, Chengzhang Shi, Jie Han, Liang Yu, Nidan Qiao, Yichao Zhang, Xiaoyun Cao, Xiang Zhou, Haixia Cheng, Huijin Feng, Cheng Luo, Zhiyu Li, Bing Zhou, Zhao Ye, Yao Zhao
The p300 Inhibitor A-485 Exerts Antitumor Activity in Growth Hormone Pituitary Adenoma. The Journal of clinical endocrinology and metabolism 107 (6) (2022)
Jian Lin, Liuyu Hu, Chao Chen, Huijin Feng, Yang Yu, Yaxi Yang, Bing Zhou
Rhodium-Catalyzed Twofold Unsymmetrical C-H Alkenylation-Annulation/Thiolation Reaction To Access Thiobenzofurans. Organic letters 23 (4) (2021)
Chao Chen, Chen Shi, Yaxi Yang, Bing Zhou
Rh(iii)-catalyzed tandem annulative redox-neutral arylation/amidation of aromatic tethered alkenes. Chemical science 11 (44) (2020)
Yaxi Yang, Rukang Zhang, Zhaojun Li, Lianghe Mei, Shili Wan, Hong Ding, Zhifeng Chen, Jing Xing, Huijin Feng, Jie Han, Hualiang Jiang, Mingyue Zheng, Cheng Luo, Bing Zhou
Discovery of Highly Potent, Selective, and Orally Efficacious p300/CBP Histone Acetyltransferases Inhibitors. Journal of medicinal chemistry 63 (3) (2020)
Zizhou Li, Senhao Xiao, Yaxi Yang, Chao Chen, Tian Lu, Zhifeng Chen, Hualiang Jiang, Shijie Chen, Cheng Luo, Bing Zhou
Discovery of 8-Methyl-pyrrolo[1,2-a]pyrazin-1(2H)-one Derivatives as Highly Potent and Selective Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitors. Journal of medicinal chemistry 63 (8) (2020)
Yanni Chen, Liuyu Hu, Liuchun Liang, Fujiang Guo, Yaxi Yang, Bing Zhou
Ruthenium(II)-Catalyzed Regioselective Ortho C-H Allenylation of Electron-Rich Aniline and Phenol Derivatives. The Journal of organic chemistry 85 (4) (2020)
Chong Qin, Yang Hu, Bing Zhou, Ester Fernandez-Salas, Chao-Yie Yang, Liu Liu, Donna McEachern, Sally Przybranowski, Mi Wang, Jeanne Stuckey, Jennifer Meagher, Longchuan Bai, Zhuo Chen, Mei Lin, Jiuling Yang, Danya N Ziazadeh, Fuming Xu, Jiantao Hu, Weiguo Xiang, Liyue Huang, Siwei Li, Bo Wen, Duxin Sun, Shaomeng Wang
Discovery of QCA570 as an Exceptionally Potent and Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of the Bromodomain and Extra-Terminal (BET) Proteins Capable of Inducing Complete and Durable Tumor Regression. Journal of medicinal chemistry 61 (15) (2018)
Yujun Zhao, Bing Zhou, Longchuan Bai, Liu Liu, Chao-Yie Yang, Jennifer L Meagher, Jeanne A Stuckey, Donna McEachern, Sally Przybranowski, Mi Wang, Xu Ran, Angelo Aguilar, Yang Hu, Jeff W Kampf, Xiaoqin Li, Ting Zhao, Siwei Li, Bo Wen, Duxin Sun, Shaomeng Wang
Structure-Based Discovery of CF53 as a Potent and Orally Bioavailable Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitor. Journal of medicinal chemistry 61 (14) (2018)
Haibin Zhou, Weihua Zhou, Bing Zhou, Liu Liu, Ting-Rong Chern, Krishnapriya Chinnaswamy, Jianfeng Lu, Denzil Bernard, Chao-Yie Yang, Shasha Li, Mi Wang, Jeanne Stuckey, Yi Sun, Shaomeng Wang
High-Affinity Peptidomimetic Inhibitors of the DCN1-UBC12 Protein-Protein Interaction. Journal of medicinal chemistry 61 (5) (2018)
Yunxiang Wu, Zhaoqiang Chen, Yaxi Yang, Jianming Zhu, Bing Zhou
Rh(III)-Catalyzed Redox-Neutral Unsymmetrical C-H Alkylation and Amidation Reactions of N-Phenoxyacetamides. Journal of the American Chemical Society 140 (1) (2017)
Yunxiang Wu, Bing Zhou
Rhodium(III)-Catalyzed Selective C-H Acetoxylation and Hydroxylation Reactions. Organic letters 19 (13) (2017)
Bing Zhou, Jiantao Hu, Fuming Xu, Zhuo Chen, Longchuan Bai, Ester Fernandez-Salas, Mei Lin, Liu Liu, Chao-Yie Yang, Yujun Zhao, Donna McEachern, Sally Przybranowski, Bo Wen, Duxin Sun, Shaomeng Wang
Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins with Picomolar Cellular Potencies and Capable of Achieving Tumor Regression. Journal of medicinal chemistry 61 (2) (2017)
Yujun Zhao, Longchuan Bai, Liu Liu, Donna McEachern, Jeanne A Stuckey, Jennifer L Meagher, Chao-Yie Yang, Xu Ran, Bing Zhou, Yang Hu, Xiaoqin Li, Bo Wen, Ting Zhao, Siwei Li, Duxin Sun, Shaomeng Wang
Structure-Based Discovery of 4-(6-Methoxy-2-methyl-4-(quinolin-4-yl)-9H-pyrimido[4,5-b]indol-7-yl)-3,5-dimethylisoxazole (CD161) as a Potent and Orally Bioavailable BET Bromodomain Inhibitor. Journal of medicinal chemistry 60 (9) (2017)